Scroll down to search for clinics conducting this clinical trial.

Study summary

<b>Metastatic Solid Tumors - Multiple Locations in the US</b>

Kinnate Biopharma is recruiting patients who have been diagnosed with BRAF mutation-positive cancers or NRAS mutation-positive melanomas to participate in a study. Patients must have a metastatic cancer (the cancer has spread from where it started) or advanced stage solid tumor. Please click the link below to learn more!

See if You Qualify

Study is available at

This study is being conducted NATIONWIDE! To find clinics conducting this study near you please use search feature below.

Study Locations